Showing results (61-70 of 202) with videos related to
Sort By:
Pageof 21
Open Forum Infectious Diseases|February 23, 2019
Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral TherapyPriya Bhagwat, Shashi N Kapadia, Heather J Ribaudo, et al.AIDS (London, England)|May 16, 2007
Chronic renal failure among HIV-1-infected patientsAmanda Mocroft, Ole Kirk, Jose Gatell, et al.Scandinavian Journal of Infectious Diseases|September 14, 2007
Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophyMarkus Bickel, Stephan Zangos, Thomas Lutz, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individualsColette J Smith, Schlomo Staszewski, Caroline A Sabin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Case-control study of diabetes mellitus in HIV-infected patientsCecilia Yoon, Roy M Gulick, Donald R Hoover, et al.Antimicrobial Agents and Chemotherapy|February 14, 2007
Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimenNils von Hentig, Axel Müller, Carsten Rottmann, et al.British Journal of Clinical Pharmacology|October 26, 2006
A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancyNils von Hentig, Amina Carlebach, Peter Gute, et al.Antiviral Therapy|November 30, 2005
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapyAlessandro Cozzi-Lepri, Lidia Ruiz, Clive Loveday, et al.HIV Clinical Trials|February 6, 2010
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)David B Clifford, Scott Evans, Yijun Yang, et al.AIDS (London, England)|November 14, 2008
Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis countryChristoph Stephan, Timo Wolf, Udo Goetsch, et al.Pageof 21